Action 603858 SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Shandong Buchang Pharmaceuticals Co., Ltd.

Actions

603858

CNE100002FV6

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 18/04/2024 		Varia. 5j. Varia. 1 janv.
16,8 CNY -0,30 % Graphique intraday de Shandong Buchang Pharmaceuticals Co., Ltd. +1,27 % -1,23 %
28/02 Buchang Pharma obtient le feu vert pour tester une combinaison de médicaments contre le cancer gastrique MT
2023 Les médicaments de Buchang Pharma restent couverts par l'assurance médicale nationale MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Tranche Update on Shandong Buchang Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 14, 2023.
Buchang Pharma Obtains Green Light to Trial Gastric Cancer Drug Combination
Tranche Update on Shandong Buchang Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 14, 2023.
Buchang Pharma’s Drugs Retain National Medical Insurance Coverage
Shandong Buchang Pharmaceuticals Co., Ltd. announces an Equity Buyback for CNY 360 million worth of its shares.
Shandong Buchang Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
Buchang Pharma's Unit Gets Nod to Test Colorectal Cancer Drug
Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Haikou Xinyingyang Investment Partnership Enterprise (Limited Partnership) and Xi Chong agreed to acquire 14% stake in Buchang Health Industry (Zhejiang ) Co., Ltd. from Shandong Buchang Pharmaceuticals Co., Ltd.,Hu Cunchao, Li Hui, and Hu Cunchao for CNY 0.
Buchang Pharma Unit Gets Nod to Trial Cancer Treatment
Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Selling Expenses of Chinese Listed Pharma Companies About 1.5x Higher Than Net Profits in 2022
Buchang Pharmaceuticals to Set Up Medical Device Subsidiary
Buchang Pharma Unit Gets Nod to Make Amendments to Diabetes Drug
Buchang Pharmaceuticals to Invest 223 Million Yuan Into Old Factory Upgrade
Buchang Pharma's Unit Passes Regulator's Good Manufacturing Practice Evaluation
Zhao Yunhua agreed to acquire a 90% stake in Buchang Taoyiyun Health Technology Co., Ltd. from Shandong Buchang Pharmaceuticals Co., Ltd. for CNY 1.
Ningbo Buchang Medical Technology Co., Ltd. announced that it expects to receive CNY 3 million in funding from Shandong Buchang Pharmaceuticals Co., Ltd., Shaanxi Deju Bowen Health Technology Co., Ltd.
Buchang Pharma Unit Passes Regulatory Inspection
Buchang Pharma Unit Gets Nod for Flu Vaccine Trials in China
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 603858
  4. Actualités Shandong Buchang Pharmaceuticals Co., Ltd.
  5. Autres langues